4
Changes in Ownership
BeOne Medicines Ltd. Filed Acc 0001628280-25-040535
SVP, General Counsel sold 11,013 shares at an average $300.45 ($3,308,877)
- SVP, General Counsel acquired 8,230 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Chan Henry SVP, General Counsel | 2025-08-13 | Sale 10b5-1 | −1,112 | $300.00 | $333,600 | 0 | D: show line 1 in the form |
| Lee Chan Henry SVP, General Counsel | 2025-08-13 | Option exercise 10b5-1 | +4,381 | $194.47 | $851,973 | 4,381 | D: show line 2 in the form |
| Lee Chan Henry SVP, General Counsel | 2025-08-13 | Option exercise 10b5-1 | +3,849 | $159.03 | $612,106 | 8,230 | D: show line 3 in the form |
| Lee Chan Henry SVP, General Counsel | 2025-08-13 | Sale 10b5-1 | −6,052 | $300.19 | $1,816,724 | 2,178 | D: show line 4 in the form |
| Lee Chan Henry SVP, General Counsel | 2025-08-13 | Sale 10b5-1 | −3,849 | $301.00 | $1,158,553 | 0 | D: show line 5 in the form |
| Open-market sales · 11,013 sh · avg $300.45 · $3,308,877 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Chan Henry SVP, General Counsel | 2025-08-13 | Option exercise · Share Option (Right to Buy) 10b5-1 | −56,953 | 131,976 | D: show line 6 in the form | ||
| Lee Chan Henry SVP, General Counsel | 2025-08-13 | Option exercise · Share Option (Right to Buy) 10b5-1 | −50,037 | 134,758 | D: show line 7 in the form |
Loading xslF345X05/wk-form4_1755290322.xml…